Quem somos

Chiesi group is an ethical pharmaceutical company devoted to research and development of drugs and new technologies for over 80 years. Today is one of the leading pharmaceutical companies in Europe having a wide range of products in therapeutic segments.

The group operates in all continents, with its headquarters in Parma, Italy and with 22 direct subsidiaries, 3 production plants (Italy, France and Brazil) and 4 research and development centers for new products and technologies (Italy, France, United States and England).

Chiesi Farmacêutica Ltda, Brazil branch, is in operation since 1976, offering health professionals and patients a good quality and reliable drugs recognized around the world.

We provide important therapy medication resources for diseases in various fields as:

  • Respiratory tract diseases (asthma and chronic obstructive pulmonary disease);
  • Allergic diseases (rhinitis and hives);
  • Cardiovascular (hypertension and angina);
  • Metabolic disorders (dyslipidaemia);
  • Musculoskeletal;
  • Poliaminoacids supplements;
  • Special Care

In addition, technologies that make the patient’s life easier, such as inhalers and spacers to drug administration used by inhalation. In this specific therapeutic area, the group developed a new technology, called Modulite® that consists in making aerosols drugs available to healthcare professionals with harmful free substances to the ozone layer, respecting the environment. It also developed tobramycin for inhaled use for pulmonary infections treatment in patients with cystic fibroses.



One of the company´s highlights was the development of pulmonary surfactant Poractant Alfa, which continues to contribute significantly reducing the mortality of new born premature births with respiratory distress syndrome.

Currently, Chiesi group has more than 3,000 employees around the world being 300 located in Brazil, which 140 are exclusively focused on scientific dissemination for more than 30,000 physicians in Brazil.

Our facilities include a manufacture plant certified by ANVISA (Brazilian Health Authorities) and European Regulatory Agencies, located in Santana de Parnaíba and an office in São Paulo.